IBB logo

IBB Overview

Profile

Name:

iShares Biotechnology ETF

Assets under management:

$6 B

Expense ratio:

0.45%

Inception date:

February 12, 2001

Last ex-dividend date:

December 17, 2024

Next ex-dividend date:

N/A

Description:

The IBB ETF, or iShares Nasdaq Biotechnology ETF, focuses on biotechnology companies. It aims to track the performance of the Nasdaq Biotechnology Index, providing investors exposure to the biotech sector, including drug development and research firms. It's popular for those seeking growth in healthcare innovation.
Name
Weight
9.70 %
AMGN logo
Amgen(AMGN)
8.60 %
3.35 %
ARGX logo
argenx SE(ARGX)
2.91 %
WAT logo
Waters(WAT)
2.17 %
2.11 %
NTRA logo
Natera(NTRA)
2.00 %
BIIB logo
Biogen(BIIB)
1.90 %
ILMN logo
Illumina(ILMN)
1.47 %
BeiGene(ONC)
1.45 %
INCY logo
Incyte(INCY)
1.30 %
1.12 %
MRNA logo
Moderna(MRNA)
1.11 %
0.99 %
PCVX logo
Vaxcyte(PCVX)
0.95 %
EXEL logo
Exelixis(EXEL)
0.94 %
0.84 %
RGEN logo
Repligen(RGEN)
0.81 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Dividend yield

Name
Weight
9.70 %
AMGN logo
Amgen(AMGN)
8.60 %
3.35 %
ARGX logo
argenx SE(ARGX)
2.91 %
WAT logo
Waters(WAT)
2.17 %
2.11 %
NTRA logo
Natera(NTRA)
2.00 %
BIIB logo
Biogen(BIIB)
1.90 %
ILMN logo
Illumina(ILMN)
1.47 %
BeiGene(ONC)
1.45 %
INCY logo
Incyte(INCY)
1.30 %
1.12 %
MRNA logo
Moderna(MRNA)
1.11 %
0.99 %
PCVX logo
Vaxcyte(PCVX)
0.95 %
EXEL logo
Exelixis(EXEL)
0.94 %
0.84 %
RGEN logo
Repligen(RGEN)
0.81 %

Analyst ratings

FAQ

  • What is IBB?
  • Does IBB pay dividends?
  • What stocks are in IBB?
  • What is the current assets under management for IBB?
  • What is IBB average volume?
  • What is IBB expense ratio?
  • What is IBB inception date?

What is IBB?

The IBB ETF, or iShares Nasdaq Biotechnology ETF, focuses on biotechnology companies. It aims to track the performance of the Nasdaq Biotechnology Index, providing investors exposure to the biotech sector, including drug development and research firms. It's popular for those seeking growth in healthcare innovation.

Does IBB pay dividends?

Yes, the iShares Biotechnology ETF does pays dividends, with the most recent payment being $0.06 per share. The last ex-dividend date was on December 17, 2024, and the next ex-dividend date has not been announced yet

What stocks are in IBB?

As of today, iShares Biotechnology ETF inlcudes 259 holdings, with 254 of them being companies from 15 different countries and 1 sectors. The most weighted holdings are Gilead Sciences (9.7%), Amgen (8.6%) and Vertex Pharmaceuticals Incorporated (8.38%)

What is the current assets under management for IBB?

Assets under management of iShares Biotechnology ETF is $6 B

What is IBB average volume?

Average volume of iShares Biotechnology ETF is $1 M

What is IBB expense ratio?

Expense ratio of iShares Biotechnology ETF is 0.45%

What is IBB inception date?

Inception date of iShares Biotechnology ETF is February 12, 2001